Oscar Health Inc. (NYSE: OSCR) reported Q4 EPS of ($1.24), $0.35 worse than the analyst estimate of ($0.89). Revenue for the quarter came in at $2.81 billion versus the consensus estimate of $3.11 billion.

GUIDANCE:

Oscar Health Inc. sees FY2026 revenue of $18.7-19 billion, versus the consensus of $12.756 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.